New England--Rhode Island — Providence, Rhode Island

New England--Rhode Island is a clinical research site located in Providence, Rhode Island, United States 02906.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New England--Rhode Island has participated in 1 clinical trials.

Therapeutic areas: Alzheimer Disease.

Sponsors: Wake Forest University Health Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New England--Rhode Island?

New England--Rhode Island has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New England--Rhode Island conducted?

New England--Rhode Island has 1 clinical trials on record. Their work covers Alzheimer Disease.

Is New England--Rhode Island accredited by Crixeo Health?

New England--Rhode Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New England--Rhode Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.